NCT02655302View on ClinicalTrials.gov

Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 4, 2018

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Pulmonary Disease, Chronic ObstructiveBacterial Infections
Interventions
OTHER

Sample collecting

Collect sputum, blood and nasopharyngeal swab during the exacerbation and at steady state 8 to 16 weeks later.

OTHER

Lung function measure

Measure lung function and follow it during 4 years

Trial Locations (4)

59037

RECRUITING

University hospital of Lille, Lille

59100

RECRUITING

Roubaix hospital, Roubaix

59113

NOT_YET_RECRUITING

Seclin hospital, Seclin

59200

RECRUITING

Tourcoing hospital, Tourcoing

All Listed Sponsors
lead

University Hospital, Lille

OTHER